Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

• Status: Completed
• Trial end date: 2021-01-21
• Target enrollment: 0
• Participant gender: All

Summary

This study is to evaluate the effect of food on the pharmacokinetics of a single dose of ASC41 tablet in healthy volunteers, comparing fasting and postprandial pharmacokinetic parameters of Tmax, Cmax, AUC0-t, AUC0-∞.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gannex Pharma Co., Ltd.
• Collaborator: Hunan Provincial People's Hospital

Criteria

Key Inclusion Criteria:

• 19kg/m2 ≤ BMI <40kg/m2.

Key Exclusion Criteria:

• A history of thyroid disease.

• History of, or current liver disease.